Long COVID: Symptoms, Causes, and How AI Is Ushering New Hope
Long COVID is a chronic state that can be diagnosed when symptoms or diagnosable conditions persist for at least three months following a SARS-CoV-2 infection. It falls under a broader category known as post-acute sequelae of SARS-CoV-2 infection (PASC) and is recognized as a newly emerging infection-associated chronic condition (IACC). What makes Long COVID particularly […]
Generative AI in Pharma: Revolutionizing Drug Discovery for Rare Diseases
The pharmaceutical industry is on the cusp of a revolution. Generative AI, as highlighted in McKinsey’s 2024 report, is transforming how drugs are discovered, developed, and brought to market. By enhancing R&D processes, reducing costs, and accelerating timelines, this technology has the potential to reshape the future of healthcare. At Delta4, we are leveraging big-data-driven […]
Delta4 Featured on PharmaVentures Podcast: AI in Drug Discovery
Delta4’s CEO, Kurt Herpel, and CSO, Klaus Kratochwill, were recently featured on the PharmaVentures podcast, where they discussed how Delta4 is transforming the landscape of drug discovery through AI. This engaging conversation sheds light on the roots of the company and the innovative work happening at Delta4, as well as the potential of AI to […]
The Role of Drug Combination in Modern Medicine: Delta4’s Innovative Approach
The use of multiple active ingredients in medicine is a time-honored practice, with roots stretching back to Traditional Chinese Medicine (TCM) and various formulations in traditional medicine across the world based on the combination of plant and natural substances [24764197, 29799486, 36114271]. Combining multiple active ingredients, also known as drug combinations, is an increasingly important […]
Delta4: A Trusted Partner in EU Horizon Research Projects
Delta4 is proud to announce its participation in two significant EU Horizon research projects: PICKED (Personalized Medicine in Chronic Kidney Disease) and PROMOTE (Prostate Cancer Omics Mediated Intervention). Horizon Europe is the world’s largest research funding program, focusing on advancing health, biomedical research, data science, and AI/ML. With a total budget of nearly EUR 100 […]
Leveraging Multi-Omics Data for Drug Repurposing and Discovery at Delta4
At Delta4, we leverage multi-omics data to identify novel drug repurposing opportunities by uncovering molecular similarities between diseases and existing drugs. This integrative approach holds promise for accelerating the development of effective treatment strategies across rare and complex conditions. What is Omics Data? Omics data refers to comprehensive datasets that capture various types of molecular […]
The Path to New Therapies for Focal Segmental Glomerulosclerosis (FSGS)
Developing new treatments for complex diseases presents a myriad of challenges, ranging from understanding the disease’s mechanisms to ensuring the safety and effectiveness of proposed therapies. At Delta4, we’re passionately pursuing new treatments for Focal Segmental Glomerulosclerosis (FSGS). Leveraging our in-silico platform, Hyper-C, we’ve been able to identify new potential therapeutic options for FSGS. This […]
What to Expect From The Pharmaceutical Industry In 2024
As we step into 2024, the pharmaceutical industry stands at the cusp of remarkable advancements and significant transformations. This year promises to be a pivotal one, with key trends, innovations, and challenges shaping the future of healthcare and medicine and defining the pharmaceutical landscape. Key Pharmaceutical Industry Trends to Watch in 2024 Let’s explore the […]
Advancing Healthcare Through Drug Discovery Services: Unleashing the Power of Innovation
In the realm of healthcare, the journey from a promising drug idea to an effective therapy is not a straightforward one. The process of drug discovery is highly complex and generally takes years from the initial idea to – in an ideal scenario – the final approval. It requires experts from different fields, therefore making […]
What is Drug Discovery? Unveiling the Process, Challenges, and Future
In the intricate world of healthcare, the journey of a drug from a basic idea to a therapy that can change lives is a challenging one. This process, known as drug discovery, is a rigorous, meticulous, and elaborate journey that requires a high level of expertise in various fields such as biology, chemistry, computer science, […]